https://orcid.org/0000-0003-2549-2569
References
- Gould GS , HurstJR , TroforAet al. Recognising the importance of chronic lung disease: a consensus statement from the Global Alliance for Chronic Diseases (Lung Diseases group). Respir. Res.24(1), 15–21 (2023).
- Xu JF , GaoYH , SongYL , QuJM , GuanWJ. Research advances and clinical management of bronchiectasis: chinese perspective. ERJ Open Res.8(2), 00017–02022 (2022).
- Chalmers JD , ElbornS , GreeneCM. Basic, translational and clinical aspects of bronchiectasis in adults. Eur. Respir. Rev.32(168), 230015–230028 (2023).
- Chalmers JD , AlibertiS , AltenburgJet al. Transforming clinical research and science in bronchiectasis: EMBARC3, a European Respiratory Society clinical research collaboration. Eur. Respir. J.61(6), 2300769–2300775 (2023).
- Huang Y , ChenCL , YuanJJet al. Sputum exosomal microRNAs profiling reveals critical pathways modulated by Pseudomonas aeruginosa colonization in bronchiectasis. Int. J. Chron. Obstruct. Pulmon. Dis.14, 2563–2573 (2019).
- Glasgow AMA , DeSanti C , GreeneCM. Non-coding RNA in cystic fibrosis. Biochem. Soc. Trans.46(3), 619–630 (2018).
- Gaul R . Development of an Integrated Device-RNAi Particle Platform for the Treatment of Cystic Fibrosis via Inhalation[PhD Thesis].Royal College of Surgeons in Ireland, 123 St Stephen’s Green, Dublin 2, Ireland (2022).
- Wang Y , LyuX , WuX , YuL , HuK. Long non-coding RNA PVT1 a novel biomarker for chronic obstructive pulmonary disease progression surveillance and acute exacerbation prediction potentially through interaction with microRNA-146a. J. Clin. Lab. Anal.34(8), e23346–e23354 (2020).
- Ge J , GengS , JiangH. Long noncoding RNAs antisense noncoding RNA in the INK4 locus (ANRIL) correlates with lower acute exacerbation risk, decreased inflammatory cytokines, and mild GOLD stage in patients with chronic obstructive pulmonary disease. J. Clin. Lab. Anal.33(2), e22678–e22685 (2019).
- Tang S , DingY , ZhouZ , YangW. Identification and bioinformatic analysis of circRNAs in the plasma of patients with very severe chronic obstructive pulmonary disease. BMC Pulm. Med.23(1), 211–221 (2023).
- Miao Y , WuJ , WuR , WangE , WangJ. Circ_0040929 serves as promising biomarker and potential target for chronic obstructive pulmonary disease. Int. J. Chron. Obstruct. Pulmon. Dis.17, 2079–2092 (2022).
- Chen S , YaoY , LuSet al. CircRNA0001859, a new diagnostic and prognostic biomarkers for COPD and AECOPD. BMC Pulm. Med.20(1), 311–320 (2020).
- Flume PA , BasavarajA , GarciaBet al. . Towards development of evidence to inform recommendations for the evaluation and management of bronchiectasis. Respir. Med.211, 107217–107227 (2023).
- De Santi C , FernándezFernández E , GaulRet al. Precise targeting of miRNA sites restores CFTR activity in CF bronchial epithelial cells. Mol. Ther.28(4), 1190–1199 (2020).
- Oglesby IK , VenckenSF , AgrawalRet al. miR-17 overexpression in cystic fibrosis airway epithelial cells decreases interleukin-8 production. Eur. Respir. J.46(5), 1350–1356 (2015).
- Vencken S , FogedC , RamseyJMet al. . Nebulised lipid-polymer hybrid nanoparticles for the delivery of a therapeutic anti-inflammatory microRNA to bronchial epithelial cells. ERJ Open Res.5(2), 00161–02018 (2019).
- Sonneville F , RuffinM , CorauxCet al. MicroRNA-9 downregulates the ANO1 chloride channel and contributes to cystic fibrosis lung pathology. Nat. Commun.8(1), 710-720 (2017).
- Song R , WalentekP , SponerNet al. miR-34/449 miRNAs are required for motile ciliogenesis by repressing cp110. Nature510(7503), 115–120 (2014).